Genentech, Inc., one of the world’s leading biotech companies, has obtained a licence for Desert Scientific Software’s, Proasis2 and Proasis3 protein structure database and visualisation systems.
Desert Scientific Software (DesertSci), a chemo/bioinformatics software company based in Sydney, Australia is pleased to announce the licensing of their flagship products, Proasis2 and 3, by one of the world’s major biotech companies, Genentech, Inc., CA, USA.
Proasis2, is the industry’s leading protein structure database and visualization system and enables Genentech research staff to make better use of protein structure data in their small molecule drug discovery programs. Proasis3 is the powerful upgrade to the system that includes a sleek new interface, added functionality, faster performance and an enhanced user experience.
Click here to find out more about Proasis2